Table 1: Pre-operative clinical data: sex, age at disease onset, disease duration, anti-epileptic drugs (AEDs), epileptogenic temporal lobe (defined by EEG seizure onset), MRI, hemisphere dominance assessed by fMRI and pre-operative neuropsychological test results.

Nr/Id/Sex Age at disease onset Disease duration (yrs) AED at time of investigation Epileptogenic temp lobe (to be resected) Hemisphere dominance by word generation fMRI MRI pathology CD List recall
(SD) 		CD Delayed recall
(SD) 		RCFT
delayed recall
(SD)
1/M 28 13 CBZ R TL Left R mesial sclerosis -0.5 0.3 -0.5
2/F 17 18 LTG, GBP R TL Not available R occipital demarcated infarction; R hc atrophy 0.3 0.5 -2.2
3/M 47 7 LTG, VPA R TL Left 0 0.5 0.7 0.7
4/F 34 5 LEV, CBZ, PGB R TL Not available 0 1 0.6 -1.3
5/F 34 4 CBZ R TL Not available 0 -0.5 -0.2 -2.3
6/F 8 19 LTG R TL Not available R mesial sclerosis -1.6 -2.5 -2.6
7/M 15 32 LEV L TL Not available L TL suspect DNET -0.7 -1.3 0.5
8/M 19 4 VPA, LTG L TL Left L TL suspect DNET -1.4 0.1 -1.9
9/F 1 31 LTG, CLB L TL Not available L mesial sclerosis 0.1 -2.1 -1.1
10/F 19 12 PGB, CBZ L TL Not available L mesial sclerosis -3.3 -2.7 --*
11/M 25 5 OXC L TL Not available L TL low-grade astrocytoma 0.8 -4.5 -1.6
12/F 10 20 LTG, VPA L TL Not available L mesial sclerosis -0.2 -0.1 0.0
13/F 13 11 LTG L TL Left 0 -0.8 -0.8 -1.2
14/F 32 28 LEV, OXC L TL Not available L mesial sclerosis -2.2 -0.5 -1.3

*Not able to perform
CBZ Carbamazepine; LTG Lamotrigine; GBP Gabapentin; VPA Valproic Acid; LEV Levetiracetam; PGB Pregabalin;
CLB Clobazam; OXC Oxcarbazepine. L Left; R Right; TL Temporal Lobe; DNET Dysembryoplastic Neuroepithelial Tumour; SD Standard Deviation;
CD Claseson-Dahl Learning and Retention Test; RCFT Rey Complex Figure Test